Frequently Asked Questions
What is the optimal dosage ratio for Ipamorelin and CJC-1295?
Most users find success with a ratio of approximately 2:1 (Ipamorelin:CJC-1295). A common starting point is 200 mcg Ipamorelin paired with 100 mcg CJC-1295, administered 2-3 times daily.
How long before seeing results from the Ipamorelin CJC-1295 stack?
Initial improvements in sleep and recovery can be noticed within the first 2 weeks. Visible body composition changes typically appear between weeks 4-8, with maximum results achieved after 12-16 weeks of consistent use.
Can women use the Ipamorelin CJC-1295 stack?
Yes, women can benefit from this stack. However, lower doses are recommended—typically 50-75% of male dosing protocols. Women should start at the lowest effective dose and adjust based on response.
Do I need a prescription to use Ipamorelin and CJC-1295?
These peptides are available for research and clinical use. Regulations vary by country. Always verify the legal status in your jurisdiction and consult with a healthcare professional before beginning any peptide therapy.
What blood work should I monitor while using this stack?
Recommended monitoring includes: IGF-1 levels, fasting glucose, lipid panel, liver function tests, and complete
blood count. Baseline values before starting and periodic checks during the cycle help ensure safe and effective use.